Connection
Thomas Meyer to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Thomas Meyer has written about Dose-Response Relationship, Drug.
|
|
Connection Strength |
|
 |
|
 |
|
0.032 |
|
|
|
-
Shen X, Denittis A, Werner-Wasik M, Axelrod R, Gilman P, Meyer T, Treat J, Curran WJ, Machtay M. Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. Radiat Oncol. 2011 Feb 16; 6:17.
Score: 0.017
-
Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Med Sci Monit. 2010 Feb; 16(2):CR49-55.
Score: 0.015